MasTec heads into its May 21 Q1 earnings report with the most bullish analyst tone it has seen in years — and a stock that has already priced in much of the good news.
The Street's conviction has turned almost uniformly positive. In the five days following the stock's prior earnings catalyst, analysts at Goldman Sachs, Citigroup, TD Cowen, Truist, and Keybanc all raised targets, with Goldman moving to $487 and Truist to $518. The wave continued last week: Cantor Fitzgerald lifted its target dramatically to $545, and JPMorgan nudged further to $491 while maintaining Overweight. Guggenheim stepped up to a fresh Buy, upgrading from Neutral. All 15 covering analysts now carry a buy-equivalent rating. The consensus mean target of $473 sits roughly 14% above the current price of $414.90 — a meaningful gap, but one that reflects the sharp 13% rally over the past month that the stock has already posted. The single-session pullback of 4.6% on Friday points to profit-taking at recent highs, not a fundamental reversal.
The bull case rests on MasTec's positioning across three of the strongest infrastructure buildout themes in the US: power delivery, communications, and clean energy. Revenue grew 34% year-on-year in the most recent quarter. EPS momentum ranks in the 84th percentile on a 30-day basis and the 81st percentile over 90 days — the company has been beating revised-higher estimates with consistency. Bears, however, flag that much of this optimism may already be embedded in the multiple. At roughly 42x trailing earnings and an EV/EBITDA of around 9.4x on a trailing LTM basis, the valuation leaves limited room for execution misses. Supply chain risk in pipeline infrastructure and heavy reliance on a small number of large power delivery contracts are the specific vulnerabilities bears point to. Net margins remain thin at under 2%, which means any cost pressure hits earnings disproportionately hard.
Insider activity adds a note of caution. In March, the founding Mas family — CEO José Mas, Chairman Jorge Mas, and COO Robert Apple — collectively sold over $16 million in stock at prices near $297-$298. Those sales were made well below current levels, so the framing matters: the family still controls roughly 20% of shares outstanding, and the sales may have been routine. But the timing, with the stock now trading 40% above those March exit prices, means the print will face scrutiny on whether the fundamental trajectory justifies the re-rating.
Short-side pressure is contained. Short interest of just under 4% of free float has edged up about 20% over the past month in share terms, but the borrow market is loose — availability remains wide and the cost to borrow has ticked up to 0.49% but is nowhere near levels that signal squeeze risk. Options positioning is mildly constructive: the put/call ratio of 0.67 is below its 20-day average of 0.78, meaning calls are dominating open interest relative to recent norms. The question Thursday's print answers is whether MasTec's backlog growth and margin trajectory are strong enough to validate a stock trading near all-time highs — and whether management's guidance is bold enough to keep the analyst upgrade cycle alive.
See the live data behind this article on ORTEX.
Open MTZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
